According to Aeterna Zentaris's latest financial reports the company's current revenue (TTM) is $6.62 M. In 2021 the company made a revenue of $5.26 M an increase over the years 2020 revenue that were of $3.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $6.62 M | 26.01% |
2021 | $5.26 M | 44.03% |
2020 | $3.65 M | 586.47% |
2019 | $0.53 M | -98.02% |
2018 | $26.88 M | 2812.35% |
2017 | $0.92 M | 1.32% |
2016 | $0.91 M | 67.16% |
2015 | $0.54 M | 4854.55% |
2014 | $0.01 M | -99.82% |
2013 | $6.17 M | -81.66% |
2012 | $33.66 M | -6.62% |
2011 | $36.05 M | 30.14% |
2010 | $27.7 M | -56.19% |
2009 | $63.23 M | 64.37% |
2008 | $38.47 M | -8.45% |
2007 | $42.02 M | 1.36% |
2006 | $41.45 M | -82.84% |
2005 | $0.24 B | 27.52% |
2004 | $0.18 B | 50.28% |
2003 | $0.12 B | 94.26% |
2002 | $64.89 M | 135.37% |
2001 | $27.57 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $51.82 B | 781,855.34% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $47.62 B | 718,455.57% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $46.15 B | 696,324.26% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | N/A | N/A | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | $0.66 B | 9,859.51% | ๐บ๐ธ USA |